CML: A Method for Cellular Typing

  • D. J. Schendel
  • W. Jennert
  • K. Bickert
  • R. Wank

Abstract

Cell-mediated lympholysis (CML) can be used as a cellular typing method to identify surface molecules that are recognized by cytotoxic T lymphocytes (CTLs). The target molecules recognized by CTLs in many cases correlated with HLA specificities (either class I or class II) that can be defined with serological reagents. On the other hand, several studies have clearly demonstrated that CTLs can detect HLA determinants that do not correspond to known serological specificities [1–9]. In several cases the CTL-defined specificities have been shown biochemically to represent distinct class I molecular variants, for example for HLA- A2, B27, and B44 [10–13]. Other CTLs have been described which show lysis of allogeneic target cells that share no serologically detectable HLA-A, B, C, or DR specificities with the sensitizing cells, and further investigation will be required to define the genetic and molecular basis of these anomalous CML reactions [14–16]. It is certainly clear that CTLs are unique reagents for identifying minor histocompatibility antigens in man and for defining the molecular epitopes important in HLA restriction [17–20].

Keywords

Influenza Tral Doyle Kato 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kristensen T, Grunnet N, Kissmeyer-Nielsen F (1974) Cell mediated lympholysis in man. Occurrence of unexpected, HLA (“LA” and “Four”) irrelevant lympholysis. Tissue Antigens 4: 378–382Google Scholar
  2. 2.
    Mawas C, Christen Y, Legrand L, Sasportes M, Dausset J (1974) Cellular and humoral response against determinants other than the classical HLA specificities. Transplant 18: 256–266CrossRefGoogle Scholar
  3. 3.
    Schapira M, Jeannet M (1974) Cell-mediated lympholysis in HLA identical unrelated individuals. Tissue Antigens 4: 178–182PubMedCrossRefGoogle Scholar
  4. 4.
    Kristensen T, Grunnet N (1975) Cell mediated lympholysis in man. Evidence of a separate CML locus within the major histocompatibility complex and an approach to CML typing. In: Kissmeyer-Nielsen F (ed). Histocompatibility testing 1975. Munksgaard, Copenhagen, p 835Google Scholar
  5. 5.
    Goulmy E, Termijtelen A, Bradley B, van Rood JJ (1976) HLA restriction of non-HLA-A, -B, -C, and -D cell me-diated lympholysis ( CML ). Tissue Antigens 8: 317–326Google Scholar
  6. 6.
    Long MA, Handwerger BS, Amos DB, Yunis EJ (1976) The genetics of cell mediated lympholysis. J Immunol 177: 2092–2099Google Scholar
  7. 7.
    Tekolf WA, Biddison WE, Aster RD, Shaw S (1982) Two subgroups of HLA Bw44 defined by cell-mediated lym-pholysis that differ in Bw44 expression on platelets and in patterns of genetic linkage disequilibrium. J Immunol 129: 1474–1478PubMedGoogle Scholar
  8. 8.
    Kato S, Ivanyi P, Lacko E, Breur B, du Bois R, Eijsvoogel VP (1982) Identification of human CML targets. HLA-B locus (B12) antigen variants defined by CTL generated between B-locus-identical (B12) responder- stimulator pairs. J Immunol 128: 949–955PubMedGoogle Scholar
  9. 9.
    Breuning MH, Lucas CJ, Breur BS, Engelsma MY, DeLange GG, Dekker AJ, Biddison WE, Ivanyi P (1982) Subtypes of HLA-B27 detected by cytotoxic T lym-phocytes and their role in self-recognition. Hum Immunol 5: 259–268PubMedCrossRefGoogle Scholar
  10. 10.
    Biddison WE, Kostyu DD, Strominger JL, Krangel MS (1982) Delineation of immunologically and biochemically distinct HLA-A2 antigens. J Immunol 129: 730–734PubMedGoogle Scholar
  11. 11.
    van der Poel JJ, Molders HH, Thompson A, Ploegh H. (1983) Definition of four HLA-A2 subtypes by CML typing and biochemical analysis. Immunogenetics 17: 603–608Google Scholar
  12. 12.
    Molders HH, Breuning MH, Ivanyi P, Ploegh H (1983) Biochemical analysis of variant HLA-B27 antigens. Hum Immunol 6: 111–117PubMedCrossRefGoogle Scholar
  13. 13.
    Hahn AW, Schendel DJ, Wendelboe Hansen P, Ploegh H. Biochemical and cellular identification of HLA- Bw44 subtypes. Hum Immunol (in press)Google Scholar
  14. 14.
    Ward MJ, Stiller CR, McGirr DA, Fung M, Cousins HK, Paty DW, Hawson WT, Sinclair NRSTC (1977) CML problems and possibilities defining specificities. Trans-plant Proc 9: 1781–1784Google Scholar
  15. 15.
    Kristensen T (1978) Studies on the specificity of CML. Report from a CML workshop. Tissue Antigens 11: 330–349PubMedCrossRefGoogle Scholar
  16. 16.
    Schendel DJ, Wank R, Dupont B (1978) Cell-mediated lympholysis: examination of HLA genetic fine structure and complementation using cytotoxic lymphocytes. Eur J Immunol 8: 634–640PubMedCrossRefGoogle Scholar
  17. 17.
    Goulmy E, Termijtelen A, Bradley BA, van Rood JJ (1977) H-Y antigen killing by women is restricted by HLA. Nature 266: 544–546PubMedCrossRefGoogle Scholar
  18. 18.
    Dickmeiss E, Soeberg B, Svejgaard A (1977) Human cell-mediated cytotoxicity against modified target cells is restricted by HLA. Nature 270: 526–528PubMedCrossRefGoogle Scholar
  19. 19.
    McMichael AJ, Ting A, Zweerink HJ, Askonas BA (1977) HLA restriction of cell-mediated lysis of influenza virus-infected human cells. Nature 270: 524–526PubMedCrossRefGoogle Scholar
  20. 20.
    Elkins WL, Pierson G, Negendank W, Zier KS (1982) Recognition of minor lymphocyte alloantigen(s) on cells of HLA matched siblings and unrelated individuals by cytotoxic T lymphocytes in vitro. Immunogenetics 15: 485–499PubMedCrossRefGoogle Scholar
  21. 21.
    Bradley BA, Charmot D, Goulmy E, Johnson HE, Kristensen T, Mawas C, Pfeffer P, Schendel DJ, Wank R (1980) Histocompatibility typing by cell mediated lym-pholysis (CML): workshop II technical standardization. Tissue Antigens 16: 73–90PubMedCrossRefGoogle Scholar
  22. 22.
    European CML Study Group (1980) Human his-tocompatibility testing by T cell mediated lympholysis: a European standard CML technique. Tissue Antigens 16: 335–367Google Scholar
  23. 23.
    Breuning MH, Tekolf WA, Kato S, Breur BS, Engelsma MY, Spits H, Ivanyi P (1983) High resolution HLA typing by cytotoxic T lymphocytes. Transplant Proc 15: 118–122Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • D. J. Schendel
    • 1
  • W. Jennert
    • 1
  • K. Bickert
    • 1
  • R. Wank
    • 1
  1. 1.Institute for ImmunologyUniversity of MunichMunich 2Federal Republic of Germany

Personalised recommendations